New Study Says a Fractional Laser May Shift Skin's Aging Markers at the DNA Level

A fresh peer-reviewed study on a nonablative fractional laser found real shifts in skin's epigenetic aging markers. Here's what the science actually shows, and what it doesn't.

What the New Study Actually Found

In late June, researchers published a peer-reviewed paper in the journal Scientific Reports, part of the Nature Portfolio, looking at whether a nonablative fractional laser can shift the molecular markers tied to skin aging, not just the way skin looks in a mirror. The study followed 22 adults using a split-face design, meaning each person had one side of the face treated and the other left as a built-in comparison, across three total laser sessions.

Using tape strip samples and a technique that profiles millions of DNA methylation sites across the epidermis, researchers tracked how those markers changed over nine months. Across the large majority of aging associated sites they looked at, the direction of change ran opposite to what is typically seen as skin ages, trending back toward a younger looking molecular pattern. One of the study's lead researchers, Dr. Konika Patel Schallen, called it "an important first step toward understanding the biology" behind what providers already see in the treatment room.

On the visible side, the treated skin showed a meaningful drop in brown spot appearance within the first month, with changes to the underlying methylation patterns building steadily through three months and then holding fairly steady through the rest of the nine month tracking window.

Why 'Epigenetic' Is the Word Everyone's Using

DNA methylation is basically a chemical tagging system layered on top of your genes that can turn certain genetic instructions up or down without changing the underlying DNA sequence. As skin ages, this tagging pattern shifts in fairly predictable ways, which is part of why scientists have started treating it as a kind of biological clock for tissue.

What makes this study interesting is that it looks past surface texture and pigment, which lasers have targeted for years, and asks whether treatment can also nudge that underlying tagging pattern. That is a different kind of evidence than a before and after photo, and it fits a broader shift in aesthetic medicine toward biology-first data alongside visible outcomes.

What This Does (and Doesn't) Prove

It's worth being clear about the limits here. This was a small, company-backed pilot study with 22 participants, and the researchers themselves were careful to frame the findings as an association between treatment and methylation changes, not proof that the laser prevents skin cancer or reverses aging in any broad sense. Larger, independent studies over longer timelines would help confirm whether these patterns hold across different skin types, ages and treatment protocols.

None of this is medical advice, and it isn't a promise that any laser or device will produce a specific result for your own skin. If anything, it's a reminder that the science behind familiar treatments keeps evolving, and that asking a provider what a device is actually cleared and studied for is always a reasonable question.

A Desert City Angle

For Las Vegas skin, which deals with a lot of sun exposure, dry air and constant swings between indoor AC and outdoor heat, pigment and texture concerns like the brown spots tracked in this study are common conversation starters at consult. Studies like this one are part of why providers keep an eye on the research behind devices already sitting in treatment rooms, even when the science is still early.

If a nonablative fractional laser or any other pigment-focused treatment has been on your radar, a licensed provider can talk through what's realistic for your skin, your sun history and your goals, rather than relying on a press release alone.

How to Read a Study Like This One

Headlines about lasers 'reversing aging' can get ahead of the actual science. Here's a quick guide to what matters when a new aesthetic device study crosses your feed.

1. Who paid for it: This study was conducted by the device maker in partnership with an outside research lab. That doesn't make it invalid, but it's worth knowing who funded the work.
2. How many people were involved: Twenty two adults is a normal size for an early pilot study, but it's still too small to call the results universal.
3. Split-face design: Comparing treated and untreated skin on the same person is a smart control, since it rules out normal side to side differences between people.
4. What was actually measured: Researchers tracked DNA methylation markers from lab samples, not just before and after photos, which is a more technical kind of evidence.
5. How long they followed up: Nine months of tracking is longer than many aesthetic device studies, though still short compared to how slowly skin actually ages.
6. Visible change versus cellular change: A drop in brown spot appearance at one month is separate from the deeper methylation shifts, which took longer to show up and settle.
7. What the authors didn't claim: The researchers were careful to say this shows an association with aging markers, not proof of preventing skin cancer or reversing aging broadly.
8. Ask your own provider: The most useful next step is usually a conversation with a licensed provider about your own skin and history, not the press release.

← More from the Bella Med Spa blog